Search research articles
Contact Us
Filters
Showing results (11-20 of 72) with videos related to
Page
of 8
Sort By:
Lancet (London, England)
|
February 7, 2002
Treatment of cervical cancer
Jacoba van der Zee, Peter C M Koper, Ludovicus C H W Lutgens, et al.
International Urogynecology Journal
|
March 6, 2010
Prevalence of major levator abnormalities in symptomatic patients with an underactive pelvic floor contraction
Anneke B Steensma, Maja L Konstantinovic, Curt W Burger, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
July 20, 2007
Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate
Herman A M Verheul, Leen J Blok, Curt W Burger, et al.
Molecular and Cellular Endocrinology
|
July 5, 2011
Interaction between sex hormones and WNT/β-catenin signal transduction in endometrial physiology and disease
Paul H van der Horst, Yongyi Wang, Marten van der Zee, et al.
Journal of the Society for Gynecologic Investigation
|
January 5, 2005
Steroid-modulated proliferation of human endometrial carcinoma cell lines: any role for insulin-like growth factor signaling?
Susanne C J P Gielen, Eline E Hanekamp, Leen J Blok, et al.
Human Reproduction (Oxford, England)
|
July 2, 2003
Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment
Evelien J de Boer, Isolde den Tonkelaar, Egbert R te Velde, et al.
Journal of the Society for Gynecologic Investigation
|
October 6, 2005
Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin
Susanne C J P Gielen, Curt W Burger, Liesbeth C M Kühne, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
April 25, 2008
Signaling by estrogens and tamoxifen in the human endometrium
Susanne C J P Gielen, Lindy A M Santegoets, Payman Hanifi-Moghaddam, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
July 25, 2006
Optimal treatment of premature ovarian failure after treatment for Hodgkin's lymphoma is often withheld
Sylvia I Verschuuren, Jiska J Schaap, Mars B Van't Veer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 4, 2009
Prediction of residual disease after primary cytoreductive surgery for advanced-stage ovarian cancer: accuracy of clinical judgment
Cornelis G Gerestein, Dirkina W van der Spek, Marinus J Eijkemans, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 72) with videos related to
Sort By:
Page
of 8
Lancet (London, England)
|
February 7, 2002
Treatment of cervical cancer
Jacoba van der Zee, Peter C M Koper, Ludovicus C H W Lutgens, et al.
International Urogynecology Journal
|
March 6, 2010
Prevalence of major levator abnormalities in symptomatic patients with an underactive pelvic floor contraction
Anneke B Steensma, Maja L Konstantinovic, Curt W Burger, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
July 20, 2007
Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate
Herman A M Verheul, Leen J Blok, Curt W Burger, et al.
Molecular and Cellular Endocrinology
|
July 5, 2011
Interaction between sex hormones and WNT/β-catenin signal transduction in endometrial physiology and disease
Paul H van der Horst, Yongyi Wang, Marten van der Zee, et al.
Journal of the Society for Gynecologic Investigation
|
January 5, 2005
Steroid-modulated proliferation of human endometrial carcinoma cell lines: any role for insulin-like growth factor signaling?
Susanne C J P Gielen, Eline E Hanekamp, Leen J Blok, et al.
Human Reproduction (Oxford, England)
|
July 2, 2003
Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment
Evelien J de Boer, Isolde den Tonkelaar, Egbert R te Velde, et al.
Journal of the Society for Gynecologic Investigation
|
October 6, 2005
Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin
Susanne C J P Gielen, Curt W Burger, Liesbeth C M Kühne, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
April 25, 2008
Signaling by estrogens and tamoxifen in the human endometrium
Susanne C J P Gielen, Lindy A M Santegoets, Payman Hanifi-Moghaddam, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
July 25, 2006
Optimal treatment of premature ovarian failure after treatment for Hodgkin's lymphoma is often withheld
Sylvia I Verschuuren, Jiska J Schaap, Mars B Van't Veer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 4, 2009
Prediction of residual disease after primary cytoreductive surgery for advanced-stage ovarian cancer: accuracy of clinical judgment
Cornelis G Gerestein, Dirkina W van der Spek, Marinus J Eijkemans, et al.
Page
of 8